Trials / Unknown
UnknownNCT03175146
A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely
Stereotactic Body RadioTherapy (SBRT) for Oligo-metastatic Colo-rectal Cancer With Bio-marker Evaluation for Early Progression
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- AHS Cancer Control Alberta · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The proposed study will evaluate if "curative intent" SBRT can provide high response rates and clinically meaningful cancer control with acceptable toxicity specifically in patient with metastatic colorectal cancer (mCRC) who do not have surgical options and are no longer responding to systemic therapy
Detailed description
SBRT for Oligo-metastatic Colorectal cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation Therapy | 5 treatments given over 2 weeks |
Timeline
- Start date
- 2017-09-01
- Primary completion
- 2021-01-01
- Completion
- 2021-01-01
- First posted
- 2017-06-05
- Last updated
- 2017-06-07
Source: ClinicalTrials.gov record NCT03175146. Inclusion in this directory is not an endorsement.